Tivantinib in combination with Carboplatin and Pemetrexed as first line treatment in patients with advanced non-squamous NSCLC or Malignant Pleural Mesothelioma: results of phase I trial

Autor:	Monica Bertossi, F. De Vincenzo, Chiara Miggiano, C. Bonifacio, Paolo Andrea Zucali, Matteo Simonelli, Antonella Santoro, F. Mrakic Sposta, Laura Giordano, Matteo Perrino, Giuseppe Fatuzzo
Rok vydání:	2015
Předmět:	Oncology medicine.medical_specialty business.industry Pleural mesothelioma Hematology Carboplatin First line treatment chemistry.chemical_compound Pemetrexed chemistry Non squamous Internal medicine Medicine In patient business medicine.drug
Zdroj:	Annals of Oncology. 26:vi78
ISSN:	0923-7534
DOI:	10.1093/annonc/mdv343.18
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::bedbc49f04bfed11d7058f47695334e2 https://doi.org/10.1093/annonc/mdv343.18 Zobrazit plný text záznamu